
### [MONDO:0015360](http://purl.obolibrary.org/obo/MONDO_0015360)
**Label:** autosomal dominant hereditary axonal motor and sensory neuropathy

**Subclasses:** [MONDO:0011916](http://purl.obolibrary.org/obo/MONDO_0011916) (Charcot-Marie-tooth disease axonal type 2K), [MONDO:0014720](http://purl.obolibrary.org/obo/MONDO_0014720) (autosomal dominant optic atrophy plus syndrome), [MONDO:0018993](http://purl.obolibrary.org/obo/MONDO_0018993) (Charcot-Marie-tooth disease type 2), [MONDO:0011468](http://purl.obolibrary.org/obo/MONDO_0011468) (hereditary motor and sensory neuropathy, Okinawa type), [MONDO:0019551](http://purl.obolibrary.org/obo/MONDO_0019551) (hereditary motor and sensory neuropathy type 6), 

**Corr. equiv. classes:** [OMIM:616648](http://purl.obolibrary.org/obo/OMIM_616648), [OMIM:607831](http://purl.obolibrary.org/obo/OMIM_607831), [Orphanet:101097](http://www.orpha.net/ORDO/Orphanet_101097), [Orphanet:90117](http://www.orpha.net/ORDO/Orphanet_90117), [Orphanet:64746](http://www.orpha.net/ORDO/Orphanet_64746), [OMIM:604484](http://purl.obolibrary.org/obo/OMIM_604484), [Orphanet:90120](http://www.orpha.net/ORDO/Orphanet_90120), [Orphanet:1215](http://www.orpha.net/ORDO/Orphanet_1215), 

**Class expressions from DL-Learner:**

- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and (not ([HP:0040078](http://purl.obolibrary.org/obo/HP_0040078) (Axonal degeneration))) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and (not ([HP:0011096](http://purl.obolibrary.org/obo/HP_0011096) (Peripheral demyelination))) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and (not ([HP:0007107](http://purl.obolibrary.org/obo/HP_0007107) (Segmental peripheral demyelination))) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and (not ([HP:0003621](http://purl.obolibrary.org/obo/HP_0003621) (Juvenile onset))) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and (not ([HP:0003481](http://purl.obolibrary.org/obo/HP_0003481) (Segmental peripheral demyelination/remyelination))) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) 62.50%
- [HP:0003202](http://purl.obolibrary.org/obo/HP_0003202) (Skeletal muscle atrophy) and [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0003701](http://purl.obolibrary.org/obo/HP_0003701) (Proximal muscle weakness) 62.50%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) 53.32%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0040290](http://purl.obolibrary.org/obo/HP_0040290) (Abnormality of skeletal muscles) 53.32%
- [HP:0003380](http://purl.obolibrary.org/obo/HP_0003380) (Decreased number of peripheral myelinated nerve fibers) and [HP:0030236](http://purl.obolibrary.org/obo/HP_0030236) (Abnormality of muscle size) 53.32%


